Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Todd Bazemore | President and Chief Operating Officer | 2024-01-04 | 1,405 | $6.74 | $9.47kSell |
Romulus K. Brazzell | Head of Research and Development and Chief Medical Officer | 2024-01-04 | 1,617 | $6.74 | $10.90kSell |
Mark T. Iwicki | CHIEF EXECUTIVE OFFICER | 2024-01-04 | 4,539 | $6.73 | $30.55kSell |
Darius Kharabi | CHIEF BUSINESS OFFICER | 2024-01-04 | 1,385 | $6.73 | $9.32kSell |
Mary Reumuth | CHIEF FINANCIAL OFFICER | 2024-01-04 | 1,227 | $6.74 | $8.27kSell |
Eric Trachtenberg | Chief Legal Officer Chief Compliance Officer and Secretary | 2024-01-04 | 1,227 | $6.74 | $8.27kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Rajeev M. Shah | 773.64% | 21,789,226 | $143.07M | Insider |
Ra Capital Management LP | 626.12% | 17,634,380 | $115.79M | Insider |
Gregory Grunberg | 193.57% | 5,451,860 | $35.80M | Insider |
Orbimed Advisors LLC | 122.42% | 3,447,840 | $22.64M | Insider |
Mark T. Iwicki | 10.17% | 286,315 | $1.88M | Insider |
Baker Bros Advisors LP | 9.47% | 266,613 | $1.75M | Institution |
Hongming Chen | 7.26% | 204,515 | $1.34M | Insider |
Millennium Management LLC | 4.71% | 132,674 | $871.14k | Institution |
Romulus K. Brazzell | 3.25% | 91,473 | $600.61k | Insider |
Eric Trachtenberg | 2.42% | 68,066 | $446.92k | Insider |